Sunday, November 16, 2025 3:17:04 PM
So, I'm not worried about missing the high point of a short squeeze. But I do hope it squeezes to $10 or more at approval, as Smith projects. And I'm prepared for it to squeeze much further.
I also realize that it might not happen at all, or it might be a tiny squeeze. It's been two years of waiting for the MHRA to approve. During this time the UK health services have given us all kinds of signals that approval is coming. It's hard to imagine that some of the naked shorts haven't gotten out already, and maybe they have. If they are out, I'll hold my shares and wait for the multiple other financial events to be announced by management, as they have promised us in past 10Qs. The share price will go up as the company makes money and begins to give up guidance on the future. I will only take off what I need and I don't need much, or my family has needs, and I have a big family. Most of my shares I plan to keep for those who need it more than I do.
Longs, be aware that shorts will try to get your shares at a steal for a few dollars. They'll tell you there's no more upside. But that line has already been proven wrong. (Think UK payment on a case-by-case basis for ALL CANCERS, which I interpret as a pre-approval, along with compassionate care through the Specials program!)
I frankly believe that even $10 is a steal. So, my final advice, and I seldom, if ever, give advice, is to only cash out shares for money you actually need in the moment. Realize the shares will go up in price naturally as the company begins to manufacture and sell DCVax and announces plans to expand.
GLTL
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM
Eco Science Solutions Integrates IDScan.net's DIVE Into Herbo Pay to Power Identity Verification, Compliance, and Fraud Prevention • ESSI • Mar 27, 2026 12:01 PM
The Crypto Company Acquires FRAME Blockchain's Technology, An "Interstate Highway" Liquidity Layer for Crypto Commerce • CRCW • Mar 26, 2026 12:28 PM
Resilient Energy Inc. Enters LOI Negtiations for Second Acquisition; First Acquisition Nears Closing • RENI • Mar 26, 2026 10:30 AM
Alliance Creative Group (ACGX) Releases 2025 Annual Financial and Disclosure Report • ACGX • Mar 26, 2026 8:30 AM
Isiah Enterprises Activates Scalable Materials Platform Targeting $900B+ Global Market Opportunity; Initiates Strategic Partner Alignment Phase • OWPC • Mar 25, 2026 9:07 AM
ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi • ECGI • Mar 24, 2026 8:30 AM
